Tori Amos On World Cafe | WAMU 88.5 - American University Radio

NPR : World Cafe

Filed Under:

Tori Amos On World Cafe

For more than 20 years, Tori Amos has been one of the most inventive and distinctive singer-songwriters in contemporary music. With eight Grammy nominations and millions of albums sold worldwide, Amos has become a living legend. Her solo career has evolved unpredictably, from acoustic piano to electronica and orchestral styles.

Amos' latest release — her 12th solo album — came together when she was approached by Deutsche Grammophone, a German classical label, and invited to compose a 21st-century song cycle based on classical-music themes. The result is Night Hunters, an album steeped in classical traditions which pays homage to Bach, Chopin and Debussy, and which showcases Amos' classical piano training in the process. In today's installment of World Cafe, Amos plays live and talks with WXPN host Michaela Majoun about some of the record's guest players, from the Apollon Musagete Quartet to Berlin Philharmonic clarinetist Andreas Ottensamer.

This segment originally aired on January 13, 2012.

Copyright 2012 WXPN-FM. To see more, visit http://www.xpn.org/.

NPR

From Bond Girl To Medicine Woman: Jane Seymour's Big Break

The actress is best known for her role as Dr. Quinn, the physician on the American frontier. But her big break came years before, when she played 007's tarot-reading love interest in Live and Let Die.
NPR

'Into The Wild' Author Tries Science To Solve Toxic Seed Mystery

Jon Krakauer has long been haunted by how Christopher McCandless died in the Alaskan wilderness. In a scientific journal, he and a chemist show that the seeds McCandless consumed can contain a toxin.
NPR

5 Things You Should Know About Ben Carson

The pediatric neurosurgeon, who entered the presidential race Sunday night, performed pioneering operations on conjoined twins and hasn't held public office before. Here's what you might not know.
NPR

The Promise And Potential Pitfalls Of Apple's ResearchKit

Apple's new mobile software platform is designed to help collect data for medical research, but concerns have been raised about privacy and informed consent.

Leave a Comment

Help keep the conversation civil. Please refer to our Terms of Use and Code of Conduct before posting your comments.